Editas Medicine | 2.34 -0.01 -0.43% | ||
| EDIT | |||
| 高 2.46 | 开 2.37 | 量 248.12万股 | 总市值 2.28亿 |
| 低 2.34 | 换 2.54% | 额 587.86万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
OYang
11-04 22:37
#药闻简讯# Azalea Therapeutics 公司筹集 8200 万美元，致力于研发用于治疗癌症和自身免疫性疾病的体内 CAR-T 疗法。
不再支持 CRISPR 技术。$Intellia(NTLA)$ $CRISPR Therapeutics(CRSP)$ $Editas Medicine(EDIT)$
不再支持 CRISPR 技术。$Intellia(NTLA)$ $CRISPR Therapeutics(CRSP)$ $Editas Medicine(EDIT)$
8赞
Editas Medicine(EDIT)
12-02 06:15
$Editas Medicine(EDIT)$ 144 Report of proposed sale of securities Accession Number: 0001650664-25-000158 Act: 33 Size: 4 KB 网页链接
Editas Medicine(EDIT)
12-05 05:45
$Editas Medicine(EDIT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001650664-25-000161 Size: 4 KB 网页链接
Editas Medicine(EDIT)
12-05 05:45
$Editas Medicine(EDIT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001650664-25-000163 Size: 4 KB 网页链接
Editas Medicine(EDIT)
12-05 05:45
$Editas Medicine(EDIT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001650664-25-000162 Size: 5 KB 网页链接
Editas Medicine(EDIT)
11-10 20:15
$Editas Medicine(EDIT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001650664-25-000153 Act: 34 Size: 318 KB 网页链接
Editas Medicine(EDIT)
11-11 05:15
$Editas Medicine(EDIT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001650664-25-000156 Act: 34 Size: 5 MB 网页链接
Editas Medicine(EDIT)
10-10 04:35
$Editas Medicine(EDIT)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001650664-25-000148 Act: 34 Size: 191 KB 网页链接